Galamon, Renaldo A.

HRN: 23-54-56  Sex: Male

Patient Encounter


Audit Details

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
08/18/2023
CEFUROXIME 750MG (VIAL)
08/18/2023
08/25/2023
IVTT
700mg
Q8
Intestinal Parasitism
Checking Final Appropriateness 

Indication:  Empiric    Type of Infection:  Intra-abdominal    Compliance to guidelines: Compliant To Guidelines

Initial appropriateness: Yes   

Intervention



Type of Intervention done:

                    

           


Acceptance: